| 摘要 |
FIELD: biotechnologies.SUBSTANCE: invention describes the methods of determination of: A?(1-17) peptide in a sample; whether a subject has a moderate form of Alzheimer's disease; whether a subject has a moderate cognitive disorder with a prodromal form of Alzheimer's disease and monitoring of Alzheimer's disease. The methods include determination of action or level of A?(1-17) peptide on the basis of amount of the revealed marker.EFFECT: invention represents the methods allowing to distinguish patients with moderate form of Alzheimer's disease, with prodromalny form with non-prodrom moderate cognitive disorder, with non-prodrom moderate cognitive decrement.8 cl, 6 dwg, 3 tbl, 4 ex |
